OncoSec Medical (ONCSQ) Competitors

ONCSQ vs. VIVE, KLDO, GNCA, HTGMQ, GRFS, LVTX, MYNZ, NLSP, PHVS, and PROC

Should you be buying OncoSec Medical stock or one of its competitors? The main competitors of OncoSec Medical include Viveve Medical (VIVE), Kaleido Biosciences (KLDO), Genocea Biosciences (GNCA), HTG Molecular Diagnostics (HTGMQ), Grifols (GRFS), LAVA Therapeutics (LVTX), Mainz Biomed (MYNZ), NLS Pharmaceutics (NLSP), Pharvaris (PHVS), and Procaps Group (PROC). These companies are all part of the "medical" sector.

OncoSec Medical vs.

OncoSec Medical (NASDAQ:ONCSQ) and Viveve Medical (NASDAQ:VIVE) are both medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, community ranking, media sentiment, valuation, dividends, profitability, earnings, analyst recommendations and risk.

Viveve Medical has higher revenue and earnings than OncoSec Medical.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
OncoSec MedicalN/AN/A-$34.18MN/AN/A
Viveve Medical$6.43M0.00-$22.03MN/AN/A

In the previous week, OncoSec Medical's average media sentiment score of 0.00 equaled Viveve Medical'saverage media sentiment score.

Company Overall Sentiment
OncoSec Medical Neutral
Viveve Medical Neutral

OncoSec Medical has a beta of -18.22, suggesting that its stock price is 1,922% less volatile than the S&P 500. Comparatively, Viveve Medical has a beta of 0.09, suggesting that its stock price is 91% less volatile than the S&P 500.

Company Net Margins Return on Equity Return on Assets
OncoSec MedicalN/A N/A N/A
Viveve Medical N/A N/A N/A

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
OncoSec Medical
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A
Viveve Medical
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A

Viveve Medical received 311 more outperform votes than OncoSec Medical when rated by MarketBeat users.

CompanyUnderperformOutperform
OncoSec MedicalN/AN/A
Viveve MedicalOutperform Votes
311
73.70%
Underperform Votes
111
26.30%

Summary

Viveve Medical beats OncoSec Medical on 4 of the 4 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ONCSQ and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

ONCSQ vs. The Competition

MetricOncoSec MedicalPharmaceutical IndustryMedical SectorNASDAQ Exchange
Market CapN/A$6.78B$5.23B$7.98B
Dividend YieldN/A2.72%44.24%3.91%
P/E RatioN/A15.66126.7917.23
Price / SalesN/A316.172,373.9285.85
Price / CashN/A34.4236.8831.98
Price / BookN/A5.795.504.64
Net Income-$34.18M$138.82M$105.95M$217.28M

OncoSec Medical Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
VIVE
Viveve Medical
0 of 5 stars
$0.00
flat
N/A-99.4%$3,000.00$6.43M0.0047
KLDO
Kaleido Biosciences
0 of 5 stars
N/AN/AN/A$4,000.00$1.10M0.0076News Coverage
GNCA
Genocea Biosciences
0 of 5 stars
N/AN/AN/A$6,000.00$1.91M0.0074Analyst Forecast
News Coverage
HTGMQ
HTG Molecular Diagnostics
0 of 5 stars
$0.00
flat
N/AN/A$6,000.00$6.37M0.0053Gap Up
GRFS
Grifols
3.3451 of 5 stars
$7.47
+2.5%
$10.50
+40.6%
-11.3%$0.00$7.13B0.0023,737News Coverage
LVTX
LAVA Therapeutics
1.8767 of 5 stars
$2.89
-5.6%
$6.00
+107.6%
+38.9%$0.00$6.77M-1.8237Positive News
MYNZ
Mainz Biomed
0.9154 of 5 stars
$0.63
-6.0%
$6.00
+854.7%
-86.8%$0.00$900,000.00-0.3865Upcoming Earnings
Gap Up
High Trading Volume
NLSP
NLS Pharmaceutics
0 of 5 stars
$0.15
+7.1%
N/A-85.1%$0.00N/A0.006News Coverage
Positive News
PHVS
Pharvaris
0.9631 of 5 stars
$20.80
-1.7%
$31.50
+51.4%
+131.3%$0.00N/A-7.7682Gap Up
PROC
Procaps Group
1.2273 of 5 stars
$2.80
+1.8%
$4.50
+60.7%
-41.0%$0.00$409.92M5.385,500

Related Companies and Tools

This page (NASDAQ:ONCSQ) was last updated on 5/19/2024 by MarketBeat.com Staff

From Our Partners